M&A Deal Summary |
|
|---|---|
| Date | 2012-02-07 |
| Target | Scarista |
| Sector | Healthcare Services |
| Buyer(s) | Prismic Pharmaceuticals |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2011 |
| Sector | Life Science |
Prismic Pharmaceuticals, Inc. is a pharmaceutical company dedicated to addressing the opioid crisis by developing novel non-addictive prescription drugs for the treatment of pain, inflammation, and neurological disorders, based on formulations utilizing the company’s micro-PEA development platform (palmitoylethanolamide with particle sizes of 0.6 – 10 microns). Prismic Pharmaceuticals, Inc. was founded in 2011 and is based in Worcester, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2012 M&A | 1 of 1 |